Rituximab-associated Progressive Multifocal Leukoencephalopathy Derived from Non-Hodgkin Lymphoma: Neuropathological Findings and Results of Mefloquine Treatment

被引：21

作者：

Sano, Yasuteru ^{[1
]}

Nakano, Yuta ^{[1
]}

Omoto, Masatoshi ^{[1
]}

Takao, Masaki ^{[2
]}

Ikeda, Eiji ^{[3
]}

Oga, Atsunori ^{[3
]}

Nakamichi, Kazuo ^{[4
]}

Saijo, Masayuki ^{[4
]}

Maoka, Takashi ^{[5
]}

Sano, Hironori ^{[1
]}

Kawai, Motoharu ^{[1
]}

Kanda, Takashi ^{[1
]}

机构：

[1] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Yamaguchi, Japan

[2] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Brain Bank Aging Res, Tokyo, Japan

[3] Yamaguchi Univ, Grad Sch Med, Dept Pathol, Yamaguchi, Japan

[4] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan

[5] Res Inst Prod Dev, Tsukuba, Ibaraki, Japan

来源：

INTERNAL MEDICINE | 2015年 / 54卷 / 08期

基金：

日本学术振兴会;

关键词：

non-Hodgkin lymphoma; progressive multifocal leukoencephalopathy; rituximab; mefloquine; JC polyoma virus; ADVERSE DRUG EVENTS; MULTIPLE-SCLEROSIS; IN-VITRO; NATALIZUMAB; THERAPY; PATIENT; PROJECT; DISEASE;

D O I：

10.2169/internalmedicine.54.2308

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 66-year-old man with non-Hodgkin lymphoma (NHL) developed progressive multifocal leukoencephalopathy (PML) after undergoing chemotherapy including rituximab. Although the administration of mefloquine at a dose of 500 mg weekly temporarily led to a dramatic decrease in the copy number of JC Virus DNA in the cerebrospinal fluid, the patient's symptoms gradually worsened. The CD4(+) T count remained continuously low, at least until approximately five months after the last cycle of chemotherapy. A postmortem examination performed 10 months after the onset of PML disclosed a severe condition associated with rituximab-treated PML originating from NHL and a high mefloquine concentration in the brain. The accumulation of further data regarding mefloquine treatment in PML cases may help to elucidate the optimal dosage and time window for effectively treating PML.

引用

页码：965 / 970

页数：6

共 21 条

[1] PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY - A HITHERTO UNRECOGNIZED COMPLICATION OF CHRONIC LYMPHATIC LEUKAEMIA AND HODGKINS DISEASE [J].

ASTROM, KE ;

MANCALL, EL ;

RICHARDSON, EP .

BRAIN, 1958, 81 (01) :93-&

[2] Mefloquine Improved Progressive Multifocal Leukoencephalopathy in a Patient with Systemic Lupus Erythematosus [J].

Beppu, Minako ;

Kawamoto, Michi ;

Nukuzuma, Souichi ;

Kohara, Nobuo .

INTERNAL MEDICINE, 2012, 51 (10) :1245-1247

[3] PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section [J].

Berger, Joseph R. ;

Aksamit, Allen J. ;

Clifford, David B. ;

Davis, Larry ;

Koralnik, Igor J. ;

Sejvar, James J. ;

Bartt, Russell ;

Major, Eugene O. ;

Nath, Avindra .

NEUROLOGY, 2013, 80 (15) :1430-1438

[4] Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro [J].

Brickelmaier, Margot ;

Lugovskoy, Alexey ;

Kartikeyan, Ramya ;

Reviriego-Mendoza, Marta M. ;

Allaire, Norm ;

Simon, Kenneth ;

Frisque, Richard J. ;

Gorelik, Leonid .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :1840-1849

[5] Monoclonal anti body-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project [J].

Carson, Kenneth R. ;

Focosi, Daniele ;

Major, Eugene O. ;

Petrini, Mario ;

Richey, Elizabeth A. ;

West, Dennis P. ;

Bennett, Charles L. .

LANCET ONCOLOGY, 2009, 10 (08) :816-824

[6] Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project [J].

Carson, Kenneth R. ;

Evens, Andrew M. ;

Richey, Elizabeth A. ;

Habermann, Thomas M. ;

Focosi, Daniele ;

Seymour, John F. ;

Laubach, Jacob ;

Bawn, Susie D. ;

Gordon, Leo I. ;

Winter, Jane N. ;

Furman, Richard R. ;

Vose, Julie M. ;

Zelenetz, Andrew D. ;

Mamtani, Ronac ;

Raisch, Dennis W. ;

Dorshimer, Gary W. ;

Rosen, Steven T. ;

Muro, Kenji ;

Gottardi-Littell, Numa R. ;

Talley, Robert L. ;

Sartor, Oliver ;

Green, David ;

Major, Eugene O. ;

Bennett, Charles L. .

BLOOD, 2009, 113 (20) :4834-4840

[7] Mirtazapine Use in Human Immunodeficiency Virus-Infected Patients With Progressive Multifocal Leukoencephalopathy [J].

Cettomai, Deanna ;

McArthur, Justin C. .

ARCHIVES OF NEUROLOGY, 2009, 66 (02) :255-258

[8] A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes [J].

Clifford, David B. ;

Nath, Avindra ;

Cinque, Paola ;

Brew, Bruce J. ;

Zivadinov, Robert ;

Gorelik, Leonid ;

Zhao, Zhenming ;

Duda, Petra .

JOURNAL OF NEUROVIROLOGY, 2013, 19 (04) :351-358

[9] Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis [J].

Clifford, David B. ;

Ances, Beau ;

Costello, Craig ;

Rosen-Schmidt, Shari ;

Andersson, Magnus ;

Parks, Deborah ;

Perry, Arie ;

Yerra, Raju ;

Schmidt, Robert ;

Alvarez, Enrique ;

Tyler, Kenneth L. .

ARCHIVES OF NEUROLOGY, 2011, 68 (09) :1156-1164

[10] The human polyomavirus, JCV, uses serotonin receptors to infect cells [J].

Elphick, GF ;

Querbes, W ;

Jordan, JA ;

Gee, GV ;

Eash, S ;

Manley, K ;

Dugan, A ;

Stanifer, M ;

Bhatnagar, A ;

Kroeze, WK ;

Roth, BL ;

Atwood, WJ .

SCIENCE, 2004, 306 (5700) :1380-1383

← 1 2 3 →